These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Assessment of respiratory function in patients with tuberculosis and chronic nonspecific bronchopulmonary disease]. Maszcyk Z; Koziorowski A Gruzlica; 1971 Aug; 39(8):803-9. PubMed ID: 5097544 [No Abstract] [Full Text] [Related]
25. The bronchial circulation. Small, but a vital attribute of the lung. Deffebach ME; Charan NB; Lakshminarayan S; Butler J Am Rev Respir Dis; 1987 Feb; 135(2):463-81. PubMed ID: 3544986 [No Abstract] [Full Text] [Related]
26. [Comparative study of spirographic values and scintigraphic aspects in patients with bronchopulmonary diseases]. Jozefovics F; Nagy L Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(2):113-5. PubMed ID: 171728 [TBL] [Abstract][Full Text] [Related]
27. [Vasoactive substances and hemodynamic shifts during changes in the vascular bed of the lungs and bronchial patency]. Goncharova VA; Syromiatnikova NV; Danilov LN; Dotsenko EK; Abramova IA Anesteziol Reanimatol; 1986; (3):40-3. PubMed ID: 3752606 [No Abstract] [Full Text] [Related]
28. [The pathophysiological and pathomorphological aspects of pulmonology]. Uglov FG Vestn Khir Im I I Grek; 1997; 156(5):88-91. PubMed ID: 9490548 [No Abstract] [Full Text] [Related]
30. [X-ray and hemodynamic parallels in patients with chronic diseases of the bronchopulmonary apparatus]. Penknovich AA; Azovskaia II Ter Arkh; 1969; 41(10):49-54. PubMed ID: 5359346 [No Abstract] [Full Text] [Related]
32. [Limitation of performance caused by fatigue of the respiratory muscles in bronchopulmonary diseases]. Smidt U; Worth H; Petro W; Böll W Verh Dtsch Ges Inn Med; 1978; (84):397-400. PubMed ID: 742067 [No Abstract] [Full Text] [Related]
33. Pulmonary function in a case of endobronchial sarcoidosis. Benatar SR; Clark TJ Am Rev Respir Dis; 1974 Oct; 110(4):490-6. PubMed ID: 4415386 [No Abstract] [Full Text] [Related]
36. [Maximum inspiratory volume per second (MIVS), inspiratory VC (IVC) and the MIVS-100-IVC ratio as indexes of bronchial obstruction]. Daddi G; Cornia G; Mannino F Ann Ist Carlo Forlanini; 1968; 28(4):331-53. PubMed ID: 5738866 [No Abstract] [Full Text] [Related]
37. [Transition of chronic bronchopulmonary diseases of childhood into adulthood; risk factors]. von der Hardt H Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():245-8. PubMed ID: 3174575 [No Abstract] [Full Text] [Related]
38. [Significance of the surfactant system for bronchopulmonary defense mechanisms]. Kohl FV; von Wichert P Prax Klin Pneumol; 1986 Sep; 40(9):365-6. PubMed ID: 3774757 [No Abstract] [Full Text] [Related]
39. [Spiroergometry in pulmonology. Indications for and comparative studies]. Brunner A; Gartmann J; Ochs D Schweiz Med Wochenschr; 1974 Dec; 104(49):1768-71. PubMed ID: 4456591 [No Abstract] [Full Text] [Related]
40. [Evaluation of the tracheobronchial clearance in patients with chronic bronchial infections by an integrated system using radioactive aerosol inhalation scintigraphy]. Matsui Y; Amitani R; Itoh H; Kuze F Bull Chest Dis Res Inst Kyoto Univ; 1991 Mar; 24(1-2):12-33. PubMed ID: 1823860 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]